Rare diseases
Investigational molecules
Locations
1500 Broadway Suite 1401, 10036-4055, United States
Nuvation Bio Inc. focuses its clinical research activity on non-small cell lung cancer, with particular attention to advanced and metastatic disease. The sponsor’s trial portfolio is centered on ROS1-positive lung cancer, reflecting a targeted interest in molecularly defined thoracic oncology.
The research landscape includes international participation across multiple countries and collaborating sites, indicating an active focus on global oncology development within this disease area.
Nuvation Bio Inc. runs clinical trials in conditions such as Non-small cell lung cancer recurrent, Non-small cell lung cancer, among others.
Clinical trials run by this sponsor – those enrolling participants first.
France
BelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
